State Street
ESLA icon

State Street’s Estrella Immunopharma ESLA Stock Holding History

State Street’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.2K Hold
43,252
– – ﹤0.01% 4255
2026
Q2 		$45K Hold
43,252
– – ﹤0.01% 4147
2026
Q1 		$45.8K Hold
43,252
– – ﹤0.01% 4143
2025
Q4 		$67.5K Buy
43,252
+20,900
+94% +$39.6K ﹤0.01% 4115
2025
Q3 		$26.6K Hold
22,352
– – ﹤0.01% 4227
2025
Q2 		$19.1K Hold
22,352
– – ﹤0.01% 4204
2025
Q1 		$20.7K Hold
22,352
– – ﹤0.01% 4203
2024
Q4 		$25.3K Buy
+22,352
New +$22.5K ﹤0.01% 4211

Other funds holding ESLA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

State Street's ESLA Position: Q3 2026 in Review

State Street held its Estrella Immunopharma (ESLA) position steady in Q3 2026 at 43,252 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4255.

State Street first reported a position in ESLA in Q4 2024 and has held it in 8 quarters since. The position peaked at $67.5K in Q4 2025. 11 funds tracked by Wall St. Rank hold ESLA as of Q3 2026.

  • State Street held 43,252 shares of Estrella Immunopharma worth $20.2K as of Q3 2026.
  • State Street left its Estrella Immunopharma share count unchanged in Q3 2026.
  • Estrella Immunopharma made up ﹤0.01% of State Street's portfolio in Q3 2026, its #4255 holding.
  • State Street first reported a position in Estrella Immunopharma in Q4 2024 and has held it in 8 quarters since.
  • State Street's Estrella Immunopharma position peaked at $67.5K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.